PRESS RELEASE

Apps interpreting data from wearable devices are helping people to live better

Making people stick to healthy behaviours is probably the biggest challenge in public health. That makes innovations which boost compliance particularly exciting.

READ MORE 7 May 2022

Sweetch Strengthens its Advisory Board with Appointment of Diabetes Care Leader, Dr. Robert A. Gabbay

Sweetch, a digital therapeutics innovator and creator of the precision engagement platform for chronic conditions, announced today that Robert A. Gabbay M.D., Ph.D. has joined the company as an advisor.

READ MORE 26 April 2022

For Obesity Management To Work, It Must Be Proactive and Empathetic

Obesity comes in many forms and for many reasons. Among the various options for treatment, different approaches work for different people. But no matter the approach, treatability and successful treatment are not the same.

READ MORE 12 April 2022

How Apps Can Help People Manage Chronic Illnesses

Conditions such as Hashimoto’s disease often require ongoing treatment and lifestyle modifications. But apps can empower patients to improve their health.

READ MORE 15 March 2022

Sweetch Wins 2022 BIG Innovation Award

Sweetch, a digital therapeutics innovator and creator of the precision engagement platform for chronic conditions, today announced it has been named a winner in the 2022 BIG Innovation Awards healthcare category, presented by the Business Intelligence Group.

READ MORE 23 January 2022

Sweetch Named to the 2021 CB Insights Digital Health 150 — List of Most Innovative Digital Health Startups

CB Insights today named Sweetch, a digital therapeutics innovator and creator of the hyper-personalized engagement platform for chronic conditions, to its third annual Digital Health 150, which showcases the 150 most promising private digital health companies in the world.

READ MORE 9 December 2021

Sweetch Adds Global Digital and Remote Health Trailblazer Prof. Joseph Kvedar as New Advisory Board Member

Sweetch, a digital therapeutics innovator and creator of the hyper-personalized engagement platform for chronic conditions, announced today that Prof. Joseph Kvedar has joined its advisory board. Prof. Kvedar brings a deep understanding of remote health, digital therapeutics, and reimbursement to Sweetch, and will focus on accelerating the commercial rollout and demonstrated positive clinical impact of the […]

READ MORE 12 October 2021

Sweetch Enters Strategic Partnership with Grupo Fleury’s Saúde iD to Tackle Brazil’s Chronic Disease Prevalence Amidst COVID-19 Pandemic

Sweetch, a digital therapeutics innovator and creator of the hyper-personalized engagement platform for chronic conditions, announced a partnership with Grupo Fleury, one of Brazil’s leading healthcare providers. Fleury will implement Sweetch as part of the company’s Saúde iD telemedicine services to improve health care outcomes for patients living with chronic conditions as part of a substantial multi-year contract.

READ MORE 22 September 2021

Sweetch raises $20M for a personalized engagement system designed to boost health outcomes

Yossi Bahagon, the founder of Sweetch, describes the company’s approach to digital reminders as a mixture of artificial intelligence and emotional intelligence. The app will use AI to analyse “lifeprint” data picked up through a smartphone. Then it delivers messages to when you might be more likely to respond to them and in a “tone […]

READ MORE 19 July 2021

Top 10 Post-Covid Tech Trends

Onsite diagnostic testing, online medical visits, and remote monitoring are just the beginning of healthcare moving into the 21st century, giving a whole new meaning to the term “digital transformation.” Startups driving this transformation include […] Sweetch, a clinically validated disease management optimization platform.

READ MORE 13 July 2021